Tokyo, Japan

Kenji Uno


Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 43(Granted Patents)


Location History:

  • Bunkyo, JP (2002)
  • Tokyo, JP (2004 - 2010)

Company Filing History:


Years Active: 2002-2010

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations in Ophthalmic Technology: The Inventions of Kenji Uno

Introduction: Kenji Uno, a talented inventor based in Tokyo, Japan, has made significant contributions to the field of ophthalmic technology. With a total of four patents to his name, his work focuses on advancements in drug delivery systems within ocular lenses, providing practical solutions that enhance patient care.

Latest Patents: Uno's latest innovations include two pivotal patents. The first is an "Ophthalmic lens capable of sustained drug release and preservative solutions therefor." This invention aims to create a stable ophthalmic lens that effectively retains and gradually releases medication. This is achieved through the use of an ionic polymer gel, which can regulate the quantity of the drug based on its efficacy. In addition, this patent outlines the formulation of a copolymer that accommodates cationic and anionic group-containing drugs for optimal drug delivery.

The second patent is for a "Highly oxygen-permeable hydrated ocular lens." This invention addresses the need for ocular lenses that possess improved surface wettability, hydration, oxygen permeability, and flexibility. By utilizing silicone-containing monomers and unique copolymer structures, this invention enhances the overall performance of ocular lenses, ensuring better comfort and visibility for users.

Career Highlights: Kenji Uno has shown remarkable skill in developing innovative ophthalmic solutions, reflecting his deep understanding of material science and biomedical engineering. His dedication to advancing ocular technology has been vital in addressing contemporary challenges in eye health and therapy, marking him as a noteworthy inventor in his field.

Collaborations: Uno's work has also benefited from collaborations with esteemed colleagues, including Takehisa Kamiya and Kazunori Kobayashi. Together, they have fostered a creative environment that encourages the exchange of ideas and expertise, further enhancing the innovations produced at Seed Company Limited.

Conclusion: Kenji Uno's inventive spirit and technical prowess have led to significant advancements in ophthalmic technology. Through his latest patents, he is setting new standards for ocular lenses that not only improve drug delivery but also enhance user comfort. His contributions continue to have a lasting impact on the field, showcasing the importance of innovation in enhancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…